Beam Therapeutics Inc.

NASDAQ:BEAM

16.88 (USD) • At close June 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 7.4730.06714.26911.7727.41316.19217.19320.11624.20820.03715.79916.6528.43251.0690.7630.0060.0060.0060.0060.0060.0060.0060.0060.00600000
Cost of Revenue 005.4755.5765.4315.3627.4757.2917.0016.18785.2875.5155.2595.01854.62345.577190.10638.02827.82619.35421.54919.13111.36811.2128.6728.8496.1276.5026.502
Gross Profit 7.4724.6248.7946.1961.979310.839.71812.82517.20713.85-69.48811.1373.17346.051-53.86-45.571-190.1-38.022-27.82-19.348-21.543-19.125-11.362-11.206-8.672-8.849-6.127-6.502-6.502
Gross Profit Ratio 10.8190.6160.5260.2670.9830.5650.6380.7110.691-4.3980.6690.3760.902-70.59-7,595.167-31,683.333-6,337-4,636.667-3,224.667-3,590.5-3,187.5-1,893.667-1,867.66700000
Reseach & Development Expenses 98.816101.44494.25887.04184.818140.077100.0597.60899.64686.34185.28774.55665.4196.78154.62345.577190.10632.45129.82519.35421.54920.21712.54312.689.1799.8529.8547.0847.084
General & Administrative Expenses 27.9428.6626.51529.62626.72443.25725.4124.65623.4922.68121.81524.06219.24717.77215.77413.40310.2738.3547.5026.9376.8126.165.4874.9773.9293.7112.8342.6622.662
Selling & Marketing Expenses 000-5.576-5.431-5.36200000000000000000000000
SG&A 27.9428.6626.51524.0521.29337.89525.4124.65623.4922.68121.81524.06219.24717.77215.77413.40310.2738.3547.5026.9376.8126.165.4874.9773.9293.7112.8342.6622.662
Other Expenses 000-87.041000000000000-0.3050000-0.064-0.00200-5.648-4.00400
Operating Expenses 126.756130.104120.773111.091106.111177.972125.46122.264123.136109.022107.10298.61884.657114.55370.39758.98200.37940.80537.32726.29128.36126.37718.0317.65713.10813.56312.6883.6953.695
Operating Income -119.286-100.037-106.504-104.895-104.132132.858-108.267-102.148-98.928-88.985-91.303-81.966-76.225-63.484-69.634-58.974-200.373-40.799-37.321-26.285-28.355-26.371-18.024-17.651-13.108-13.563-12.688-9.745-9.745
Operating Income Ratio -15.969-3.327-7.464-8.911-14.0530.42-6.297-5.078-4.087-4.441-5.779-4.922-9.04-1.243-91.263-9,829-33,395.5-6,799.833-6,220.167-4,380.833-4,725.833-4,395.167-3,004-2,941.83300000
Total Other Income Expenses Net 10.0169.6839.83613.8835.46311.30512.17919.3722.46851.6369.63810.0167.011-1.22341.516-17.279-1.187-54.6652.869-7.933-2.103-1.479-0.981-0.21-0.502-11.631-58.463-0.452-0.452
Income Before Tax -109.27-90.354-96.668-91.012-98.669144.163-96.088-82.776-96.46-37.349-107.165-71.95-69.214-64.707-28.118-76.253-201.56-95.464-34.452-34.218-30.458-27.85-19.005-17.861-13.61-25.194-71.151-10.197-10.197
Income Before Tax Ratio -14.628-3.005-6.775-7.731-13.3160.456-5.589-4.115-3.985-1.864-6.783-4.321-8.208-1.267-36.852-12,708.833-33,593.333-15,910.667-5,742-5,703-5,076.333-4,641.667-3,167.5-2,976.83300000
Income Tax Expense 0000.0395.3881.366-17.366-24.188-12.42912.41-23.45-14.022-0.134-41.51617.2790.88254.665-4.0877.9332.1030.0550.9810.210.50265.349-6.2580.1120.112
Net Income -109.27-90.354-96.668-91.051-98.669142.797-96.088-82.776-84.031-38.349-109.575-48.5-55.192-64.573-28.118-76.253-201.56-95.464-34.452-34.218-30.458-27.85-19.005-17.861-13.61-25.194-69.8-10.309-10.309
Net Income Ratio -14.628-3.005-6.775-7.735-13.3160.452-5.589-4.115-3.471-1.914-6.936-2.913-6.546-1.264-36.852-12,708.833-33,593.333-15,910.667-5,742-5,703-5,076.333-4,641.667-3,167.5-2,976.83300000
EPS -1.24-1.09-1.17-1.11-1.211.77-1.22-1.08-1.16-0.54-1.56-0.69-0.8-0.95-0.42-1.23-3.35-1.59-0.69-0.69-0.99-0.91-0.54-0.51-0.39-0.72-1.99-8.11-8.11
EPS Diluted -1.24-1.09-1.17-1.11-1.211.73-1.22-1.08-1.16-0.54-1.56-0.69-0.8-0.95-0.42-1.23-3.35-1.59-0.69-0.69-0.99-0.91-0.54-0.51-0.39-0.72-1.99-8.11-8.11
EBITDA -113.758-84.926-101.029-99.319-98.701138.22-103.08-97.332-94.281-85.041-87.83-78.548-72.913-59.689-67.884-57.305-197.801-39.527-36.103-25.14-27.255-25.844-17.116-16.793-12.373-24.661-71.087-9.719-9.719
EBITDA Ratio -15.229-2.825-7.08-8.437-13.320.437-5.995-4.839-3.895-4.244-5.559-4.717-8.647-1.169-88.97-9,550.833-32,966.833-6,587.833-6,017.167-4,190-4,542.5-4,307.333-2,852.667-2,798.83300000